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Abst ract - -We develop and analyze a model for the interactions of T-cells, antigen presenting 
cells (APCs), and HIV-1. Our model consists of five components: APCs, resting helper T-cells, 
activated uninfected helper T-cells, activated and infected helper T-cells, and the free virus. We 
emphasize the impact of APCs during HIV infection and the cell-to-cell contact manner in the trans- 
ference of HIV-1 in vivo. The existence and stability of the uninfected steady state and those of the 
infected steady states are discussed. The uniform persistence of the system is also obtained. As a 
novel approach, multiple exposures of HIV-1 are illustrated and discussed in the paper. Through 
numerical stimulations, we check the sensitivity of APCs and helper T-cells in impacting the infec- 
tion outcome and obtain some relevant results. We also give the lowest infective dose for certain 
individuals. @ 2004 Elsevier Ltd. All rights reserved. 
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l .  INTRODUCTION 
Mathematical models of the immune-pathogen systems are increasingly common. These models 
have been used to explain different phenomena. Much work has been devoted to modelling the 
viral dynamics of the human immunodeficiency virus (HIV-1), mainly due to further availability 
of quantitative information for HIV-1 [1-4]. The major themes of such studies are to investigate 
the chronic evolution of the disease and the viral diversity at equilibrium, or to estimate the 
relevant and vital infection-specific parameters. However, the more meticulous dynamics of the 
interaction between the immune system and HIV-1 pathogens during acute infection have seldom 
been studied. 
On the grounds of clinical studies, we know that most HIV-1 strains can infect both peripheral 
blood CD4 + T-cell and antigen presenting cells (we shall refer to these as APCs, including as 
dendritic ells, macrophages, and monocytes) but show great differences in efficiency of virus pro- 
duction, particularly in the case of macrophages. Some studies uggest hat virus strains that are 
poorly tropic for macrophages nter the cells but undergo limited steps in reverse transcription, 
and thus, have greatly reduced progeny production. So, for simplicity, we will assume in our 
paper that the APCs will not produce the virus, or we can say that our model is mainly based 
on the SI strain of HIV-1. 
More and more studies [5-7] have shown that there could be two ways for HIV-1 to disseminate 
in  vivo: besides entering a cell as a free infectious particle, HIV-1 also can be passed during cell- 
to-cell contact. In this process, multinucleated cells might result from syncytium formation, or 
cell-to-cell contact could take place by adherence without fusion of cell membranes. The cell-to- 
cell mechanism of HIV-1 transference has been estimated to be much more efficient han infection 
by free virus particles. Macrophage-to-lymphocyte transference ofthe virus, presumably involving 
fusion, has been shown in the presence of neutralizing antibodies. In some studies, evidence has 
been presented that HIV-1 can spread rapidly from one cell to another without formation of fully 
formed particles. Conceivably, viral nucleocapsids are transferred to a new cell during cell:cell 
fusion, with subsequent denovo reverse transcription. Thus, HIV-1 spread in the host could result 
from cell-to-cell transfer (via cores or virions) as well as from the circulating free virus. 
Also, many clinical experiments suggest hat infection with HIV-1 can always induce vigorous 
antiviral cellular and humoral immune responses. Most crucial for these two responses i  that 
both classes of T-cell dependent responses require the activity of helper T-cells. There is much 
evidence [8-10] to show that either the cell-to-cell manner or circulating viral particles can directly 
infect both resting and active T-cells, however, the resting and infected T-cells do not lead to 
productive infection unless the T-cell is activated [11-13]. This suggests that the activation of an 
infected T-cell is crucial for virus production. Therefore, mathematical models of HIV-1 infection 
should not ignore the events leading to T-cell activation, in which the antigen is presented to the 
helper T-cell on the surface of an antigen presenting cell (APC). That is to say, T-cell dependent 
responses can be regulated both at the level of the helper T-cell and at the level of the APC. To 
date, most models of the immune response to HIV-1 have ignored the role of the APC. 
We will mostly reference a paper by Fishman and Perelson [14], in which they developed a
model for the interaction of naive T-cells with APCs. In our paper, we will introduce and solve 
a phenomenologicai model of HIV-1 infection that focuses on the interaction of naive T-cells, 
HIV-1, and APCs, and in which during the binding period, T-cell can be activated and infected 
through cell-to-cell contact. That is to say, by penetrating a T helper cell's membrane and seizing 
control of its reproductive apparatus, an HIV-1 virion or even its core causes copies of itself to 
be reproduced when the cell is stimulated. These infected T helper cells are themselves targets 
of the immune system whose job is to clear virions and infected cells from the host. We assume 
that an infected activated cell may produce the virus and may die as a result of the infection, 
but it also can return to resting state. 
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Several papers have modelled the HIV-1 cell-to-cell spread dynamic model in tissue cul- 
tures [15,16]. Models describing cell-free viral spread of HIV-1 have been built much more abun- 
dantly. However, it seems that models comprising at both types of spread approaches seldom 
appear. In our paper, we combine the two approaches into one model and make some analysis 
of it. We found some interesting results, such as, the system can have two or even three infected 
steady states, and it seems that the bigger one is always stable, but the smaller one is unstable. 
We also obtain some other interesting results through numerical simulations. For example, as 
a novel approach, we decided to employ this method to model more fully the sporadic HIV-1 
exposures faced by intravenous drug users (IDUs) and those exposed through sexual contact. 
Our results from this multiple exposed approach is illustrated and discussed in Section 7. We 
also provide some numerical stimulation to check the sensitivity of APCs and T-cells in affecting 
the infection outcome and obtain some relevant results. 
This paper is organized in the following manner: the model is developed in Section 2 and the 
results provided in Sections 3-5. The numerical stimulation results can be found in Section 6 
and the discussion and conclusions are in Section 7. 
2. MODEL 
In literature [14], Fishman and Perelson presented and analyzed a model for the interaction 
of T-cells, APCs, and antigens. First, we describe the interaction mechanism briefly for the 
convenience of readers. For more details, readers can refer to [14]. 
The following chart shows the interaction etwork: 
nkb (n -- 1)kb kb 
Co + T ~- CI + T ~- ".. ~- Cn 
kd 2kd nkd  , 
~k~ ~nk~ 
Co + T* Cn-1 + T* 
where the resting T-cells are denoted by T, the healthy and activated T-cells by T*, and the 
conjugate of an APC bound with j T-cells by Cj. In detail, an APC, either an antigen-primed 
dendritic cell or a macrophage, has several T-cell binding sites [17]. After invading into in vivo, 
antigens are detected, taken up, and processed by APCs. The interaction of these APCs and 
the specific resting T-cells leads to T-cell activation, and then, T-cells translate into class T* 
from T. The binding rate between T-cells and a free site on an APC is assumed by kb, then the 
binding rate of T-cells and an APC which have i free sites will be kb multiplied by the number 
of available free sites, i. After being bound, a T-cell can also dissociate with rate kd, or it can 
become activated with rate coefficient ka. To sum up, the dissociation and activation rates per 
APC, are proportional to the total number of T-cells bound to the APC. It was also assumed 
that the population size of the APC precursors (Cp) keeps constant according to literature [18]. 
Using Ag to represent the concentration of antigen, the description above was translated into the 
model as follows [14]: 
dCo 
dt - bCpV - nkbCoT + (kd + ka)C1 - dcCo, 
dCj = (n - j + 1)kbCj_lT -- [(n -- j )kbT + j(kd + ka)]Cj 
dt 
+( j+ l ) (kd+ka)C j+ l -dcC i ,  j =1 , . . . ,n - ! ,  
dCn 
dt -  kbC~_tT - n (kd  + ka)Cn  - dcC,~, 
dT n -  1 n 
d-T = a - dTT - kbT ~ (n - j )Cj  + kd ~ jCj  + #k~T*, 
j=O j= l  
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dT*. --. ka E jC~ - k~T*, 
dt 
j= l  
dAg 
dt " = (q - eT*)Ag.  
This model represents the complicated interaction of immunity when the pathogens invade. 
More importantly, using a very ingenious technique, the authors simplified the complex model 
and made qualitative analysis of the model possible. They found that immune responses could be 
of two types: either the antigen is completely eliminated or the immune system fails to eliminate 
the antigen and chronic infection follows. These results have catholicity to antigen invading the 
immune response. However, the special antigen HIV has its own idiosyncrasies in addition to 
the common characteristics during spreading in vivo. Thus, it is necessary to build a much more 
detailed model based on the model above to examine the spread mechanism of HIV. Also, the 
predigestion technique of the model above will be used in reference by us to make our analysis 
much more thorough. 
As we have stated in Section 1, in contrast o other antigens, HIV-1 can infect T-cells. The 
cell-to-cell spread mechanism of HIV-1 transference has been estimated to be more efficient han 
infection by free virus particles. In particular, macrophage-to-lymphocyte transfer of the virus 
during the binding period has been seen as one important approach in spreading HIV. So for HIV, 
the activated T-cells, class T* in [14], should be partitioned into two types: the activated and 
healthy T-cells, and the activated and infected T-cells. Also, being the most important production 
source of HIV, the activated and infected T-cells should be regarded as an indispensable variable 
in our new model. We do not divide the resting T-cells T into the healthy and the infected since 
the resting infected T-cells do not produce viral particles unless activated. So, in our model, 
the source of the activated and infected T-cells consists of two parts: the resting T-cells infected 
through cell-to-cell transfer during the binding period or the activated and healthy T cells infected 
directly by circulating viral particles. As far as we know, many models in literature only consider 
one of these two transfers. With regard to the antigen, we will use a new express, which is different 
from that of the model in [14], to depict the dynamic according to its particular characteristics 
in reproducing and being suppressed by the immune system. 
In the following, we denote the activated and healthy T-cells by T*, the infected and activated 
T-cells by T~ and the pathogens by V, then, on the basis of the interaction scheme and the model 
in [14], our basic equations are built as follows: 
dCo = b@V - nkbCoT + (k~ + kd)C1 - deC0, 
dt 
dCj _ (n - j + 1 )kbC j - lT  - [(n - j ) kbT  + j (kd + ka)]Ci 
dt 
+ (j ÷ 1)(kd + k~)Cj+l - dcCj, j = 1 ,2 , . . . ,n -  1, 
dC ,  
= kbC~_~T - n(k~ + k~)C~ - d~C~, 
dt 
n- -1  n 
dT , • 
= a - dTT  - kbT E (n  - j )C j  + kd ~--~jCj + #krT*  + #krT~,  
d'---~ j=0 j=l 
dT* 
- 5k~ ~- ' jC j  - k~T* - kiT*V, 
dt 
j= l  
n 
dT~ 
-  'ko V'jc  - + k iT*V,  
dt Z__..w J 
j= l  
dV 
d--~ = qNT~ - k iT*V  - cV. 
(2.1) 
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In the first equation of (2.1), b is the intrinsic growth rate of APC from precursors. Since 
antigens need to bind to the precursor, we assume the rate at which APCs are generated is 
described by the mass-action term CpV. The second term in the equation represents the binding 
of a T-cell to the APC with rate kb. The third term represents the generation of a free APC by 
the dissociation of the T-cell from an APC-T-cell conjugate, which leads either to an inactivated 
T-cell, with rate kd, or to the production of an activated T-celt, with rate ka. The last term is 
the rate of decay of an APC. 
The second and third equations of (2.1) describe the rate of generation of higher-order APC- 
T cell conjugates. 
In the fourth equation of (2.1), a is the intrinsic growth rate of antigen-specific T-cells from 
the thymus. This class of cells are resting T-cells and should include two parts: resting and 
uninfected T-cells, and resting and infected T-cells due to APC-to-T-cell contact. Cells in this 
class are assumed to die at rate tiT, or become activated by interaction with an APC. The last 
two terms in the equation are the rate at which activated T-cells that are not being infected by 
HIV-1, T*, and the actively infected T-cells, T~, return to the resting state. This is assumed to 
occur with rate coefficient k~ and k'~, respectively. If the return to the rest state only occurs after 
cell division of the activated cell, then parameter p in the fourth equation would equal 2. 
In the fifth equation of (2.1), the first term models the rate of generation of activated T-cells not 
infected by HIV-1 from the resting cell-APC conjugate, which we denote with 6, where 0 < 5 < 1. 
The second term describes the return of T* cells to the resting state. The death rate of T* is 
assumed to be negligible relative to k~T*, the rate at which T* cells return to the resting state. 
The last term of the equation describes the loss of the activated T* which is infected by the 
circulating the viral particles HIV-1. 
The meaning of the sixth equation of (2.1) is similar to that of fhe fifth. The first term models 
the rate of generation of activated T-cells infected by HIV-1 through cell-to-cell contact with 
APC. For 6 and 5', 6 + 6' : 1. 
The seventh equation of (2.1) describes the dynamic of the antigen HIV-1. N is the number 
of virions produced per actively infected T-cells [19]; and q is the proportion of infection of those 
virions [20,21]. The last two terms mean that the virus infects activated cells, with the rate ki, 
and c is the rate that HIV-1 is cleared by the immune response. 
Using the similar predigestion technique of literature [14], we can simplify the system as follows: 
ds 
- -  O ' (V  - -  S ) ,  
d7 
dr 1 ~x  
d--~ !Tpv  1 + x ~2 v] 
(2.2) 
where s, x, and v are scaled variables which represent the total (scaled) population of antigen 
presenting sites, the resting T-cells and HIV virus, respectively. The conditions under which 
these coefficients are satisfied are found in Appendix A, together with the detailed technique. 
It is easy" to infer that, the positive invariance of (2.2) is D = {(s, x, v) ! s > 0, x > 0, v _> 0}. 
3. THE UNINFECTED STEADY STATE AND ITS STABIL ITY  
It is easy to obtain the uninfected steady state of equation (2.2): E0 = (0, c~, 0), which rep- 
resents the state that (2.2) is in the absence of antigens. For the stability of E0, we have the 
following. 
THEOREM 1. When 02 > 6'a/(1 + a), the uninfected stead)" state Eo = (0, c h O) is locally staSle. 
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PROOF. The characteristic equation of the linearized system at E0 of (2.2) is given by 
A(A)=(A+I )  A s+(027r+a)  A+Trcr 02 l+a)  =0" 
Obviously, all three eigenvalues have negative real parts if and only if: 02 > ~'a/(1 + a). So, 
under the condition of Theorem 1, the uninfected steady state Eo is locally stable, and when 
02 < ga/(1 + a), Eo is unstable. This completes the proof. 
Condition 02 > ~'a/(1 + a) of Theorem 1 is 
ck~rd~(dT(kd q- ka) + akb) > ~'k~akbqNnbCp. 
The values of the viral clearance factor c and the infected T-cell clearance factor k~ can both 
measure the strength of the immune system's defense against HIV-1 inoculability, while the 
values of both the viral infected factor 5~ and the viral productivity factor qN can measure the 
virus's offensive strength. The function of APC in the immune response is embodied by those 
parameters in k~, kb, and nbCp. Thus, the lower the presentation ability (nbCp) and the binding 
and activating ability (kb and k~) of the APC, the more difficult it is for an infection to be 
established. 
Now we turn to the globally asymptotical stability of E0. 
THEOREM 2. The uninfected steady state Eo of (2.2) is globally asymptotically stable under the 
conditions 
p > 01 and 02 > 5' + 5(p--O1),- 
P 
0I" 
p < 01 and 02 > 5 ~. 
PROOF. Take a Liapunov function of the form 
s Ix- l 
O- 
where M > 0, N > 0, Q > 0. The derivative of V1 along the solutions of (2.2) is then 
- -~s+ Nl+x d'r L 1 + pv J 
I z  - , 
- + - x )  + - -  
IX -- OL I SX 
Q(x - a) l + x" 
Now we consider the following two cases. 
1. When p > 01, then 
__d(V1) <d~_ M v - cr-~s + -~rr (5, + __......_~5(p-01) ) S- -  ---~--v'lr02 + -~sl 
- v -  M Q ~ ~ ' + - -  s. 
Thus, when the parameters satisfy p > 01 and 02 > 6'+ 5(p - 01)/p, we can choose proper 
positive numbers M, N, Q, s.t. 
7rO2>cr >1 7r [ 6(p -- 01)] 
d(V1) < O, and d(V,) and we will have ~ _ ~ = 0 will contain no other orbits except E0. 
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2. When p < 01, then 
d - - -~<-  v -  . Q ~6 s -  N (l +x)(m +p) '  
Thus, if these parameters satisfy p < 0t and 02 > 6', then we can choose proper M > 0, 
N>0,  Q > 0, s.t. 
7r02 > cr > i ~6' 
N 
d(v1) < 0, and d(V1) = 0 contains no other orbit except E o. We can then obtain T -- 
We complete the proof. 
Obviously, the conditions of Theorem 2 are much more difficult to satisfy than that of Theo- 
rem 1. Theorem 2 means that HIV-1 possibly cannot infect the individual if the host's immune 
system is adequately robust. As we have known, there are certain individuals who were exposed 
to the infectious virus or viral antigens but did not establish infection. 
4. THE INFECTED STEADY STATES AND THEIR  STABIL IT IES  
To obtain the infected steady states of (2.2), let the right parts of (2.2) be zero, hence, 
c~+ IH -x  
( 6(P-O_L)v~ sx =02v" 
6 '÷ l~-pv  / l÷x  
Thus, if another steady state E(s . ,  x. ,  v.) exists apart from E0, then z,  must be a positive root 
of the following equation: 
F(x)  - Ax  a + Bx  2 + Cx + D = O, 
where 
A=O2p+601-p ,  
B=(1- -~) (O2p+60L- -p )+O2p+02- -6 ' ,  
C=02+a(p- -681-O2p)  q - (1 -a )O2p,  
D=-aO2p.  
Let a = B/A ,  b = C/A,  c = D/A,  then F(z)  is equal to 
x 3 + ax 2 -4- bx -4- c = O. 
If x = y - a/3, we obtain 
where 
Suppose that the roots of 
y3 q_/~y -4- q = 0, 
a 2 2a 3 ab 
~=-- -÷b,  4- - -  ÷c. 
3 27 3 
are Yl, Y2, ya, then the respective roots of 
x 3 -4- ax  2 -4- bx ÷ c = 0 
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are  
Now let 
a a a 
x l=y l -~,  x2=y2 3' xa=ya 3" 
~2 /53 
M=- -+- - .  
4 27 
Thus, F (a )  = a(02 - 5'a),  and we can obtain an existing theorem of the infected steady state 
of (2.2). 
THEOREM 3. For the existence of the infected steady state of (2.2), we have the following. 
1. I fA>O 
(a) When M > O, and 
i. F (a)  < O, then there exists one and only one infected steady state; 
ii. F (a )  > O, then there is no infected steady state. 
(b) When M < O, and 
i. When-B+~ aA < 0 
A. F (a)  < O, then the system has one and only one infected steady state; 
(9. F (a )  > O, then there is no infected steady state. 
ii. When-B-~-3AC 3A > 0 and 
A. -B -~-ZAC 3A > a and F(c~) < O, then three infected steady states exist; 
(9. -B+~-ZAC "" 3A > a and F(a)  > O, then two infected steady states exist; 
F. -B -~-3AC 3A < ~ and F(o~) < O, then one and only one infected steady state 
exists; 
A. _ -B+~-3AC < a and F(c~) > O, then there is no infected steady state. 3A 
(c) When M = O 
i. p = q = O, then the system has no infected steady state; 
ii. t t ¢ o, and if 
4 ~--27 
A. B > 0 and F(a)  < O, then there is one infected steady state; 
@. B > 0 and F(a)  > O, then there is no infected steady state; 
F. B < O, -B -~-3AC > a and F(a)  < O, then the system has two infected 
3A 
steady states; 
A B < O, -B+~-3AC > e and F (a)  > O, then there is one and only one 
3A 
infected steady state; 
T. B < O, -B -~-SAC aA < a and F(a)  < O, then there is one and only one 
infected steady state; 
• . B < O, -B+~-3AC < a and F(a)  > O, then there is no infected steady 
3A 
state; 
2. I rA  < O, and 
(a) M > O, there is no infected steady state. 
(b) M < 0 and 
i. - B + ~  > a and F(a)  < O, then the system has two infected steady states; aA 
ii. F (a)  > O, then only one infected steady state exists; 
iii. -B+~-~AC < ~ and F(a)  < O, then there is no infected steady state. 
3A 
(c) M = 0, 
i. p = q = O, then the system has no infected steady state; 
ii. ~4 = ~-- ~ 0 and 
- -  27 
A. -B+~-aAC > a, then there is one and only one infected steady state; 3A 
(9. - -B+~- -3AC < ct, then there is no infected steady state; 3A 
F. B < 0, then there is no infected steady state. 
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The existence and the number of infected steady states of (2.2) will depend on the real condi- 
tions of both the immune system of the individual and the virus HIV. Through a lot of numerical 
simulations, it seems that the condition of having three steady states is much more difficult to 
satisfy. More details of the existence of infected steady states have been discussed in Section 6. 
Now let us look at the stability of the infected steady state E(s , ,  x,~ v,)  (if it exists). 
THEOREM 4. For (2.2) and its infected steady state E(s . ,  x . ,  v.), we have the foliovcing. 
1. I f  p >_ 01, or if p < 01 and 5(01 - p)(a + x. 2) - 02(1 + pv.) 2 < 0, the infected steady state 
E.  = (s . ,x . ,  v.) is unstable. 
x 2 2. I f  p < 01 and 5(01 - p)(a + .) - 02(1 + pv.) 2 > O, the infected steady state is locally 
stable. 
PROOF. Using the traditional method, the Jaeobian matrix of E(s . ,  x . ,  v.) is 
--0" 
X ,  
J[E = 1 -k x .  
zr02 
where v. = (x. - a)(1 + x . ) /x . .  
0 Cr 
2 
a+x.  0 
x . ( l+  x.) 
~o2(~,£- ~) ~ [(; -(_f +--~,~°1)(~* - ) 
The characteristic equation of E is 
A a + alA 2 +a2A +an = 0. 
-o21 
In which, 
+ £ [5~( ; :  ol)(x. - ~) 1 al -- x.(1 + x.) [ (1 +pv. )  2 - zoO2 - cr. , 
~2 = (1 +;v . )2  - ~ : ( iT ; . )  L ( l+pv . )2  - 0~ - ~ . ,  
~( ;  - ol) (x. - ~) (~ + £)  ~o2~,(x, - ~) 
~3 : ~.(1 +~.) (1  +p~.)2 x.(1 + ~.) 
Obviously, a3 < 0 if p > 01. Thus, all the infected steady states will be unstable under condition 
p _> 01. Hence, we assume p < 01 in the following. 
It is easy to see that under condition p < 01, we have al > 0. It is simple to prove that 
ala2 - a3 > 0 under the above conditions. Thus, 
a3 = x . ( l  + x . ) ( l  + pv,)2 x.(1 + x.) 
= ~(~*  - ~) [~(0~ - ; )  (~ +£)  - 0~(1 +p~,)~].  
x.(1 + z , ) ( t  +pv . )  2
According to the Routh-Hurwitz criterion, the stability of the infected steady state E is dependent 
on the sign of a3, that is, the sign of the expression 
~(01 - p) (~ x 2 + ,) - 02(1 + ~, )~.  
If the sign of a3 is positive, the steady state will be stable, otherwise it will be unstable. So, we 
complete the proof. 
More details of the existences and the stabilities of infected steady states are also discussed in 
Section 6. 
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5. ANALYS IS  OF  THE UNIFORM PERSISTENCE 
Now let us investigate the uniform persistence of (2.2). 
THEOREM 5. System (2.2) is uniformly persistent under condition: 02 < 5' a / (1  + a). 
PROOF. For simplicity, we solve the variable x from the second equation of (2.2) and denote it 
as x(~-). Substituting x(~-) into the first and third equations of (2.2), we can obtain the following 
nonautonomous system: 
ds 
dT a(v  s), 
[( 1 d---~ =I t  •' + l + pv ] I+X(T---------~ 
(5.1) 
Also, from (2.2), we can obtain ~]x=b > a -- b > 0 when 0 _< b < a, and 27d~ [ =~ >_ 0, sO, we 
know that there exits a t ime T 1 > 0 such that, x >__ a - ~, for all t ime t > T I, in which E is small 
enough. 
The proof will be separated into two parts: when p _> 01 and when p < 01. 
First, we prove that the conclusion of Theorem 5 is right under p _> 01. 
Since 02 < 5'a / (1  + a),  there exists a sufficiently small z > 0, such that 
~'(a - ~) (5.2) 02 < l+a-¢ '  
Notice that (x/(1 + x)) '  > 0. So under conditions p >__ 01 and x > a - ~, from (5.1) we get that 
ds s), 
dV > Tr s , 
dT -- L l+a-e  
(5.3) 
for T > 2P > T '. 
Now let us consider the following auxiliary system: 
dy__.~l = a(y2 - Yt), 
dT 
dy2 _ [~ ' (c~-¢)  ] 
d~- ~r i-T~--_-~y I - 02y2 • 
(5.4) 
From p > 01 and (5.2), it is easy to see that the linear equation (5.4) is quasi-monotonic and 
has an unique equilibrium O(0, 0) which is a saddle point. Moreover, there exits a separatrix of 
O(0, 0) apart from this in the first quadrant. For convenience, let L = lu (0 _< 1 < oc) be the 
separatrix, where u = (ul, u2), and ul and u2 are positive constants. 
Then, choose l > 0 small enough such that ( lu l , lu2)  < (s(2P),v(2P)). Suppose (Yl(~-),Y2(~-)) is 
the solution of (5.4) with yi(2b) = lui (i = 1,2), we see that (y1(7), y2(T)) monotonically increase 
when ~- > 2~ and Yi(~') --* cx~ as ~- -~ ec. The comparison principle implies that s(~-) ~ cc and 
v(~-) --* c~ as T ~ co. This completes the first part of the proof. 
Second, suppose p < 01. From (5.1), we can obtain the following: 
d8 
d---~ = a(v - s), 
__ ] dv > ~r s - 02v - 5(01 - p)vs  . 
d~- - L1 +a-e  
(5.5) 
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We can choose a const m > 0 which is small enough, s.t. 
_ 
02 < 5(81 -p )m.  
l+a  -- z 
(5.6) 
Now consider the auxiliary system 
dyl = cy(y 2 _ Yl), 
d~- 
dr 7r L\ l+a-z  
y l -02y21 • 
(5.7) 
From inequalities (5.6), we know that (5.7) is quasi-monotone and O(0, 0) is a saddle with one 
separatrix apart from it in the first quadrant. 
Now let us look at Figure 1. Consider a region between the lines v = m and v = 0 (which 
we denote as X2), and the region above line v = m (which is denoted by X1). The separatrix is 
indicated as L : v = ns. From (5.7) and inequality (5.6), we have 
dT ~2=yl =Tr [ \1  +c~-e  / J 
The separatrix in the first quadrant of (5.7) should be above the line v = s, which means n > 1. 
We denote the crossing point of line L and line v = m as (a, m). The line right of dots (a, m) on 
line v = m is denoted as I. 
/ L  v=-~ 
(m, ~) X2 
> 
Figure 1. The sketch map. 
First, we prove that the orbits of (5.1) cannot stay in region X2 forever. Otherwise, suppose 
there exists a time TO, s.t. (S(T0), V(TO)) > 0. We can find a point (y0, y0) > 0 on line L, s.t. 
S(TO) > yO, V(TO) > yO. Suppose the orbit of (5.7) which starts from point (y0 y~) at time TO is 
(yl(T), y2(T)). Using the comparison principle in region Z2, we have (S(T), V(~-)) > (YI (T), Y2(~-)) 
(when r > TO). Since (yl(T),y2('r)) --* ~ (when 7 --+ ~) ,  there exists a time 71 > To, s.t. 
(S(T1), V(T1)) in region X1. 
Second, we will prove that the orbit cannot enter region X2 from line I. Otherwise, suppose 
there exists a time ~-2, and the orbit crosses with line I at time T2. If we denote the crossing 
point as (s(v2), m), it is obvious that (s(~'2), m) > (a, m). By the comparison principle, we can 
see that v(T) < m will never happen when ~- > T2. 
Finally, consider the region B = {(s,v) [ 0 < s < a,v > m}. Since -~]s=O -- ~v > 0 and 
v > ns, we have that ~rr >- a(v -s )  > ( r (n -1 )s  :> 0 in  B (since n > 1). So, all the orbits 
of (5.1) starting from points in B will be out of B as ~- is large enough and will not come back. 
Since orbits cannot linger in )(2 forever, they will enter X1 from line I or enter region B. From 
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the above statement, we can obtain that the orbits starting from any point in R~_ must satisfy 
v(T) > m and S(T) > a as T is large enough. This means that (2.2) is uniformly persistent. We 
complete the proof. 
Theorem 5 means that, under certain conditions of the immune system and the toxicity of HIV, 
viral inoculability can lead to infection no matter how low the initial dose caused inoculation. 
Condition 02 < 6%/(1 + a) of Theorem 5 is 
ck~dc(dT(kd + ka) + akb) < 5'kaakbqNnbCp. 
The values of the viral clearance factor c and the infected T-cell clearance factor k~r can both 
measure the strength of the immune system's defense against HIV-1 inoculability, while the values 
of both the viral infected factor 6' and the viral productivity factor qN can measure the virus's 
offensive strength. The function of APC in the immune response is embodied by the parameters 
in ka, kb, and nbCp. So, the greater the presentation ability (nbCp) and the binding and activating 
ability (kb and ka) of the APC, the easier it is for an infection to be established. 
The more biological explanations of the conditions and the meanings of Theorems 1, 2, and 5 
are in Conclusion 1 of Section 7. 
6. SOME NUMERICAL  S IMULAT ION RESULTS 
In this section, we will discuss the model through numerical simulations. Considering the 
important biological meaning of the parameter 5 (or 5 ~) in the immune response to HIV, which 
represents the proportion of T-cells being infected through cell-to-cell spread while T-cells are 
being activated, we will mostly discuss the possible results when 5 (or 5 ~) changes. 
From literature, some parameter values are given as follows. 
Tab le  1. 
N 
200 ~ 1000 [19] 
ki 
klr n q 
2 [23] IO [!71 1 1 [20,21] 
1 ~ ~ i 10 5 6 X 10 4 
dT 
10--3 
10 -7  
d 
c dc  
3 [22] 0.1 [20] 
d 
k~ a # K 
[23] 0.5 ~ ~1 [14] 10-4114] 701 1/30d [24] 2 [14] 10 -s [14] 
On the basis of Table I, we  can choose p = 0.i, 7r = 50, 01 -- i, 02 -- 0.i, ~ --- I0, and  note 
that 5 -F 5 ~ = I. F rom F(~)  = a(02 - 5'~) > 0, we  know that the sys tem cannot  have three 
infected steady states by Theorem 3 and  the uninfected steady state is a lways locally stable by  
Theorem i. By  Theorem 3, we  also can obtain that the sys tem may have none, one, or two 
infected steady states, respectively, for different 5 and  5 r. F rom Append ix  B, we  know that the 
dynamics  of (2.2) and  the full sys tem (A.2) are the same, so we choose to use (A.2) in order that 
we  can also obtain the movement  paths of the infected, activated cells x$ except for virus v. These  
three possibilities are shown in Figures 2-4. The  initial values of so and  x satisfy s0(0) >__ 10 -6 
and  x(0) _> 10 -4 and  that of the other variables are assumed to be 0. T ime is scaled in terms of 
the T-cell life-span, so that one unit is about  50 days. 
For the existence and  stability of the infected steady state, we  give a further discussion. 
Through many numerical  simulations, it seems that when all parameter  values except 5 are 
fixed for an individual, then there exists an  interval [a, b] for 5 wh ich  satisfies (note 5 ~ = (i -5)).  
I. When 5 > b, then the system has no infected steady state, and  the uninfected steady 
state could be attractive in a very large region. We can possibly say that the individual 
could not be infected under  this condition since the infection capability of the antigen 
3000 
2500 
x 
2000 
1500 
~ 1000 
8 
500 
o .J 
0 0.6 0.1 0,2 0.3 0.4 0.5 
time 
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Figure 2. Movement paths of activated infected T-cells x* as a function of t ime t 
when 5 = 0.5. The system has no infected steady state (by Theorem 3), and the 
uninfected steady state is stable in a quite large region (by Theorem 2). The solid 
and the broken line are the curves of v(t) with initial values v(0) = 10 4 and 10 3, 
respectively. 
0.7 
is limited (not enough CD4 + T-cells were infected through cell-to-cell interactions while 
they were activated), which is consistent with the essentiality of cell-to-cell mechanism in 
HIV-1 transfer in vivo. 
2. When 5 < a, then the system has only one infected steady state, and it is always unstable. 
The orbits can go to the uninfected steady state, or become very large after a quite short 
period, which possibly means that the individual will be infected and develop AIDS soon 
if the amount of HIV-1 introduced is big enough. 
3. When a < 5 < b, then the system will have two infected steady states (the condition for 
having three infected steady states is very difficult to satisfy). It seems that the infected 
steady state with the lower level of v(t) is always unstable and the bigger one is locally 
stable. We also observe that the v. of the stable steady state will go up with the descent 
of ~ in an interval [a, b], which means that the antigen concentration f the infected steady 
state will change with the proportion of the infected CD4 + T-cells when the T-cells are 
activated. The bigger the proportion, the higher the level of the antigen in the infected 
steady state. 
For the system that we discussed in this section, the sketch range of In, b] is [0.09, 0.3248]. 
The lowest infective dose of HIV-1 is one of the focuses in many clinical studies. Through 
numerical simulations, we also can obtain the necessary infective dose of HIV-1 for different 
initial conditions of the immune system. For instance, for 5 = 0.2, i.e., the condition of Figure 4, 
we have Table 2, where, APC0, To, and V0 represent the initial values of APCs, resting T-celts 
and HIV antigens, respectively. 1 is the unit: liter. 
Table 2 shows that, for the initial immune conditions 10-1/1 _< APCo < 103/1 and 104/1 < 
To ~ 107/1, the lowest infective dose V0 is found at the level of 105/1. However, if initial To is 
increased to 10S/l, then the lowest infective dose will descend sharply from the level of 105 to 10. 
This is a similar interpretation of the other data of Table 2. We hope this result shows the huge 
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8 
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4.5 
(a) 
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Figure 3. Movement paths of v as function of time t when 5 = 0.01 with different 
initial value v0- The system has one and only one infected steady state (by Theo- 
rem 3) and it is unstable (by Theorem 4). The initial values are put near the infected 
steady state. The orbit goes either to the uninfected steady state (a) or becomes very 
large (b). 
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Figure 4. Movement paths of v as a function of t ime t when ~ = 0,2 with different 
initial values v(0), The system has two infected steady states (by Theorem 3). The 
smaller one is unstable (a) and the bigger one is locally stable (b) by Theorem 4. 
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Table 2. 
APC0(/1) 
To(/O 
Vo(/~) 
10 -1  ~ 103 104 ~ 105 10 a 107 10 s 
104 ~ 107 10 s 109 104 ~ 107 10 ~ 104~106 107 104 105 104 
10 s 10 10 -3  10 s 10 -2  10 s 10 -3  10 5 10 -3  10 -2  
distinction between the lowest infective dose under different conditions of the immune system 
and can provide some clues for clinical study. 
7. D ISCUSSION 
Based on literature [14], we developed a model for the interaction of HIV-1 with APCs and 
helper T-cells. The system can have two kinds of steady states: the uninfected steady state and 
the infected steady state. By linear stability analysis, we have shown that the uninfected steady 
state was loeMly stable when these parameters satisfied certain relations, and was even globally 
asymptotically stable under more rigid requirements for parameters. That is to say, HIV-1 possi- 
bly cannot infect an individual when the host's immune system is adequately robust. It is known 
that certain individuals exposed to infectious virus or viral antigens did not establish infection. 
Such high-risk exposed people include sexual partners of infected individuals, intravenous drug 
users, children born of infected mothers, and health care workers with needlestick injuries [25-27]. 
In a few subjects, the absence of the viral coreceptor (e.g., CCR-5) has been noted [28], but HIV-1 
antigen-specific production of IL-2 by PBMC can be demonstrated in some high-risk uninfected 
subjects [25]. These observations have been considered potential evidence that a predominant 
type 1 immune response occurred after exposure to HIV-1, and that the infectious virus was 
eliminated by cellular immune activity before the infection was widespread and before antiviral 
antibodies were produced. 
There may be 0-3 infected steady states of the model depending on the type of host immune 
system and the class of HIV-1. From Section 6, we know that when all of the parameter values 
except 5 are fixed for an individual, there exists an interval [a, b] for 5, in which with different 5, 
none, one, or two infected steady states can exist and these infected steady states may be stable 
or unstable (the condition for having three infected steady states is very difficult to satisfy). 
Especially for the condition with two infected steady states, the infected steady state with the 
lower v. is always unstable and the bigger one is locally stable. We also observe that the v, of the 
stable steady state will go up with the descent of 5 in an interval [a, b]. That is to say, the viral load 
after infection may tend to a infected steady state with a higher v. even if the system has another 
steady state that is much smaller. This result is consistent with studies where rhesus macaques 
were intravenously inoculated with a highly pathogenic simian/human immunodeficiency virus, 
which showed that a larger inoculum results in a more severe infection [29]. All in all, models of 
the existence of an infected steady state and its stability are quite intricate, which reflects the 
complexities of the interactions between HIV-1 and the human immune system. 
In our paper, the other obvious conclusion is that either the antigen (HIV-1) could possibly be 
cleared by certain specific host immune systems (by Theorems 1 and 2), or it will lead to their 
coexistence no matter how low the initial dose that caused inoculation (by Theorem 5). These 
observations are also found to be true in reality. Thus, an important dimensionless parameter can 
be defined whose value determines the ultimate outcome of viral inoculability. This parameter, 
which we can call the pivotal ratio, is defined as 
5' a 5'k~akbqNnbCp 
R~ - 
02(1 + a) = [dz'(kd + ka) + akb]ck'd~" 
CONCLUSION 1. I f  the pivotal ratio satisfies Rs < 1, then the virM inoculability can be cleared 
when the initial values are in a certain suitable extent. However, if the pivotal rat io satisfies 
Rs > 1, then the viral inoculability leads to infection. 
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Figure 5. Movement paths of varies of s(t), x(t), and v(~) from the pr imary to the 
fourth response for impulse injecting HIV-1. The horizontal axis is t ime and the 
vertical axis is the concentration of s(t), x(t), and v(t). The initial condition is 
so = 10 -6,  x0 ~ 10 -4,  v0 : 15, under which case the uninfected steady state is 
locally stable. On the fourth time, the uninfected state becomes unstable, which 
means that the individual will be infected after injecting HIV-1 four times. The 
interval between two injections is approximately one day. 
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F igure 6. Tra jectory  of the varies v and x of the two sys tems under  ant igenic  per tur -  
bat ion.  The  hor izontal  axis is t ime and the vert ical  axis is the concentrat ion  of x(t) 
andv(~) ,  p=0.1 ,  ~r =50,  6'1 = 1, 82 =0.1 ,  o r= 10. The in i t ia l  value is so = 10 -6  
and xo = 10 -4  wi th  v0 = 5 and v0 = 50, respectively.  
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Clearly then, the value of the pivotal ratio Rs in a certain extent determines the ultimate 
outcome of viral inoculability (infection or clearance). 
As previously noted, the values of the viral clearance factor c and the infected T-cell clearance 
factor k" can both measure the strength of the immune system's defense against HIV-1 inocula- 
bility, while the values of both the viral infected factor 6' and the viral productivity factor qN can 
measure the virus's offensive strength. The function of APC in the immune response is embodied 
by these parameters in k~, kb, and nbCp. So, the greater the presentation ability (nbCp) and 
the binding and activating ability (kb and k~) of the APC, the easier it is for an infection to be 
established. It is obvious that the cell-to-cell transfer efficiency (embodied by 5') is much greater 
than that of circulating free virus (embodied by ki). Above all, the pivotal rat io Rs reflects the 
complication of the mechanism of the interaction among HIV-1, APCs, and T-cells in vivo. 
In Theorem 1, we state that when these parameters satisfy 82 > 5'a/(1 + a), the uninfected 
steady state E0 = (0, a, 0) is locally stable. Considering the reality of the intermittent HIV-1 
inoculabilities faced through intravenous drug use and sexual contact, we made some numerical 
calculations by a fourth- or fifth-order Runge-Kutta method, and some simulations by MATLAB. 
The results indicated that under certain initial conditions, the uninfected steady state can lose its 
local stability and become unstable after several HIV-1 inoculations at time intervals of several 
days (this is illustrated in Figure 5). Under other initial conditions, the stability does not change 
even if the number of exposures exceeds ten. 
This model may be helpful to explain the phenomena where some high-risk individuals are not 
infected by the first few exposures, but finally succumb in the end. 
However, when the antigen dose is not large enough (such as v0 = 1) and the other initial 
conditions are the same as those in Figure 5, the uninfected steady state will not change its 
stability even after ten antigen inoculations, which means the individual will not be infected even 
after injecting HIV-1 ten times. This may be consistent with the observation that some IDUs 
are not infected even though they share contaminated needles. 
APPENDIX A 
In the following, we will simplify (2.1) using the same method as found in literature [14]. 
(Please refer to [14] for more details.) We denote the concentration of unoccupied sites on APCs 
by the variable So, and the concentration of occupied sites on APCs by $1, so for So and $1, we 
have the expressions 
n 7% 
So = E(n -  j)Cj, $I = E jC j .  
j=o j=1 
Substituting the above equations into (2.1) yields 
alSo _ nbCpV - kbSoT + (kd + ka)S1 - dcSo, 
dt 
dS1 
- kbSoT - (kd + ka)S1 - d~S1, 
dt 
dT 
- -  = - + #k.T~,  a dTT-  kbSoT+ kdS1 +#k~T*  ' * 
dt (A.1) 
dT* 
- SkiS1 - krT* - k~T*V, 
dt 
dT~ 5 'kaS1-  ' * dt - k~T~ + kiT*V, 
dV  
d-t = qNT~ - ksT*V  - cV. 
Using the quasi-steady state assumption, we can simplify (A.1). Since the turnover ate for 
S - T cell interactions 1/(kd + k~) is of the order of 8-16 hours [17], but the half-life of T 
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lymphocytes, even for virgin T-cells [14], is of the order of several weeks, so we can separate these 
time scales (the "fast" and the "slow" one) by scaling time in terms of the T-cell half-life. 
Now, we scale equations (A.1) as follows: 
"r = dTt, 
x = KT ,  
(# - 1)k,KnbCp V, 
dcdT 
K kb so= (# -- 1)kaKSo, sl - (# - 1)k~Ks1, 
( kd "b" ka ) ' dT  dr  
x* (# - 1 )k~KT.  ' (it - 1 )k 'K_ .  d~ 
- dT x~ --  dT '1~, a -= -~T' 
aK kd + ka kr 
o~ = dT , Z = ([z -- 1)ka' 3' -- kd 4- ka' 
dT kidcd T 3", k~ s - - -  p= - - - - - -  
kd + ka' (# - 1)krkanbCpK' kd + ka' 
nbCp kaq N k~ k~ dcdT cklr dc 
7r ~- 01 ~--- 0 2 = 
MrdcdT ' (#-  1)nbCpkrkaqN K ' qNkanbCp "
So, for (A.1), we can get an equivalently dimensionless equations as follows: 
dso 
E-g 7 
dst 
dx 
dT 
dx* 
~-g7 
~-g7 
dv 
dr ~(x~ elz*v-e2v). 
= scr(v - so) - (sox - sl), 
= (sox - Sl) - ¢~rSl, 
= ~ + (x* + x; - z) - 9(soz - s l )  - - -  
= 3'(5Sl  - z*  - px*v) ,  
= 3" (5 ' s l  - z ;  +pz*v) ,  
1 
( s l  - x*  - Xv) ,  
#-1 
(A.2) 
From Table 1 and [14], (1/dT) ~ 30 ~ 70d, 1/(kd + ka) ~ 8 ,., 16hr, so ¢ = dT/(kd + ka) 
0.0005 ~ 0.02. We will use this as a small parameter and adopt formal perturbation analysis in 
equation (A.2). 
If E = 0 in (A.2), we obtain SoX = sl. Thus, the scaled total population of antigen presenting 
sites s satisfies 
s = So + sl = (1 +x)So. 
Hence, we also can obtain 
S SX 
SO- l+ x, S l= l+ x 
Substituting e = 0 into the fourth and the fifth equations of (A.2), we obtain 
x* - 5sl _ 5sx (A.3) 
1 +pv ( l+x) (1  +pv) '  
and 
pSv ~ sx (A.4) 
x~= 5 '+ l+pv]  l+x '  
and x* + x* -- sl, which indicates, approximately, that the concentration of activated T-cells is 
in direct relation to the concentration of occupied sites on the APCs. 
Substituting equations (A.3) and (A.4) into (A.2), we can obtain the simplified (2.2) in Sec- 
tion 2. 
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Instead of formal analysis of the errors involved in using the simplified (2.2) as a substitute 
for (A.2), we  will compare  the overall dynamics  of (2.2) and (A.2) in Append ix  B. 
APPENDIX  B 
Perhaps we should use the methods  of Segel (1988) and Segel and S lemrod (1989) to examine 
formally the assumption that setting s as equal to 0 is valid, but here we will choose a non- 
qualitative method.  We just show that the assumption is valid for the parameters of interest by 
compar ing the numerical solution of (A.2) with that of (2.2). In Figure 6, we  present numerical 
solutions of the two systems (2.2) and (A.2) under antigenic perturbation. Observe that the 
dynamics  of these solutions of (A.2) are just the same as that of (2.2). 
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